Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application of Sulfhydryl Oxidase QSOX1 as a New Biomarker of Colon Cancer

NCT05827471 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05827471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05827471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application of Sulfhydryl Oxidase QSOX1 as a New Biomarker of Colon Cancer
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2023
Completion date
December 31, 2026
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer